As of 2025-10-16, the Relative Valuation of IGM Biosciences Inc (IGMS) is (12.00) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.27 USD, the upside of IGM Biosciences Inc based on Relative Valuation is -1044.8%.
The range of the Relative Valuation is (9.63) - (13.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 15.8x | 13.7x |
| Forward P/E multiples | 10.9x - 17.3x | 13.6x |
| Fair Price | (9.63) - (13.89) | (12.00) |
| Upside | -858.6% - -1193.7% | -1044.8% |
| Date | P/E |
| 2025-08-13 | -1.44 |
| 2025-08-12 | -1.48 |
| 2025-08-11 | -1.47 |
| 2025-08-08 | -1.44 |
| 2025-08-07 | -1.44 |
| 2025-08-06 | -1.46 |
| 2025-08-05 | -1.46 |
| 2025-08-04 | -1.48 |
| 2025-08-01 | -1.49 |
| 2025-07-31 | -1.44 |
| 2025-07-30 | -1.43 |
| 2025-07-29 | -1.43 |
| 2025-07-28 | -1.43 |
| 2025-07-25 | -1.44 |
| 2025-07-24 | -1.46 |
| 2025-07-23 | -1.46 |
| 2025-07-22 | -1.44 |
| 2025-07-21 | -1.46 |
| 2025-07-18 | -1.46 |
| 2025-07-17 | -1.44 |
| 2025-07-16 | -1.44 |
| 2025-07-15 | -1.54 |
| 2025-07-14 | -1.55 |